A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multicentre, Prospective Study to Assess Efficacy of Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy With High Preoperative Pulmonary Vascular Resistance
Phase: PHASE2
Conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH
Sponsor: International CTEPH Association

 
 
 
International CTEPH Association (ICA) 
 
 
PEA Bridging Study 
 
 
A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multicentre, 
Prospective Study to Assess Efficacy of Riociguat in Patients With 
Operable CTEPH Prior to Pulmonary Endarterectomy With High 
Preoperative Pulmonary Vascular Resistance 
 
 
NCT03273257 
 
 
Protocol 
 
Version 3.0, Amendment 2 
 
26APR2018